Filing Details

Accession Number:
0001213900-21-032529
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-15 16:09:41
Reporting Period:
2021-06-14
Accepted Time:
2021-06-15 16:09:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB Biological Products, (No Disgnostic Substances) (2836) 475205835
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1767226 J Timothy Schroeder C/O Inmune Bio Inc.,
1200, Prospect Street, Suite 525
La Jolla, CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-14 10,000 $19.02 136,667 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.00 to $19.01, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
  3. These shares of Common Stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares.